All News | RheumNow

All News

Best of 2020: A Rheumatologist’s Tips: Telemedicine in 6 Easy Steps

Save

d Kathryn H. Dao, M.D.

Dec 23, 2020

Ready for telemedicine/telerheumatology?

Once you and your patient agree on a virtual visit, the following suggestions may help facilitate the interaction. If you have the ability and the capacity, record the visit.

Read Article

Corona.COVID_.jpg

Best of 2020: Rheumatic Disease Drugs and COVID-19

Save

d Jack Cush, MD

Dec 22, 2020

We are in the early stages of trying to limit the morbid and mortal consequences of the corona virus pandemic of 2020. Not surprisingly, the recommendations designed to limit exposure and damage continually highlight the fact that the elderly and immunosuppressed may be amongst the most severely affected should they become infected with this virus.

This has led to a great deal of uncertainty by patients and providers about how rheumatic diseases and their treatments need to be specifically addressed.

Read Article

Plaquenil.HCQ_.pills_.jpg (keep)

Best of 2020: The Nine Lives of Hydroxychloroquine (Updated)

Save

d Martin J. Bergman, MD

Dec 21, 2020

Hydroxychloroquine is one of many medications frequently used in rheumatology practice. Its remarkable versatility is attested by its routine use in lupus, in patients with an autoimmune coagulopathy, in patients with rheumatoid arthritis, as well as in those with a low-level inflammatory arthropathy.

Read Article

#Bestof2020: A Rheumatologist’s Tips: Telemedicine in 6 Easy Steps https://t.co/p8B0dDTktT https://t.co/sHBisreYnW

Links:

https://bit.ly/37HohFd

Dr. John Cush RheumNow ( View Tweet)

Dec 23, 2020

#Bestof2020: Rheumatic Disease Drugs and COVID-19 https://t.co/82uGbNqm9R https://t.co/U0WyTL5kYZ

Links:

https://bit.ly/34EX1W6

Dr. John Cush RheumNow ( View Tweet)

Dec 23, 2020

#ACR20 Mid Meeting Recap: Gout https://t.co/MhaYjotrmb https://t.co/R4dOrSlFl6

Links:

https://bit.ly/3pgR35E

Dr. John Cush RheumNow ( View Tweet)

Dec 23, 2020

#BestACR20Tweets RT @uptoTate :Dactylitis is a clinical indicator for an aggressive phenotype of PsA categorized w/ significantly greater TJC, SJC, CRP, US synovitis/erosions in very early DMARD naïve pts. #ABS0312 #ACR20 https://t.co/d2ZjXRgvkE https://t.co/60n5pNfx9O https://t.co/EvsR0aJtXJ

Links:

Dr. John Cush RheumNow ( View Tweet)

Dec 23, 2020

#BestACR20Tweets RT @RichardPAConway : Dr Fernandez-Diaz on abatacept in RA-ILD in 263 patients. Abatacept appears safe and effective. Equivalent to RTX. Good option as s/c admin @rheumnow #ACR20 Abstr#0233 #ACRbest https://t.co/yqV6BoKy4s https://t.co/7jUASw5D2f

Links:

https://bit.ly/3h7hLum

Dr. John Cush RheumNow ( View Tweet)

Dec 23, 2020

Make sure you check out the RheumNow podcast on Soundcloud or Apple/Android devices. New episodes every week! https://t.co/wjBWCrKL34 https://t.co/3z2aWfB95V

Links:

https://bit.ly/3pjQqJ2

Dr. John Cush RheumNow ( View Tweet)

Dec 23, 2020

#Bestof2020 Goodwill Wednesday https://t.co/2mJ0xJNChL https://t.co/5SP90IVpwg

Links:

https://bit.ly/3nSZUKx

Dr. John Cush RheumNow ( View Tweet)

Dec 22, 2020

#BestACR20Tweets RT @RichardPAConway : Really important study by @SattuiSEMD on high prevalence of frailty and its impact on QOL in PMR #ACR20 @rheumnow Abstr#422 https://t.co/QzDYGsqDeJ

Dr. John Cush RheumNow ( View Tweet)

Dec 22, 2020

Autoinflammatory & Still's Disease Panel #acr20 Dr. Jack Cush leads a panel of experts regarding Still's Disease and ACR 2020. https://t.co/4GmM56l1cb https://t.co/WbXMUtz6Up

Links:

https://bit.ly/3h8CIoG

Dr. John Cush RheumNow ( View Tweet)

Dec 22, 2020

#BestACR20Tweets RT @bella_mehta : Another addition to - where you live matters! #EosinophilicFasciitis regional clustering seen in proximity to ash, landfills, chemical release sites, and combustion facilities + clustering seen in low SES and minority communities #ACR20 https://t.co/VSMYIO7EuX

Dr. John Cush RheumNow ( View Tweet)

Dec 22, 2020

Psoriatic Arthritis Panel Discussion Drs. Artie Kavanaugh, Jack Cush, Eric Ruderman and Alexis Ogdie-Beatty discuss novel issues and new drug studies from #ACR20. https://t.co/KLEBuWNHkn https://t.co/ERIT7f9rNq

Links:

https://bit.ly/3rfXurg

Dr. John Cush RheumNow ( View Tweet)

Dec 22, 2020

#Bestof2020 The Nine Lives of Hydroxychloroquine https://t.co/pDmAEXg7QH https://t.co/d7qG7DmCL9

Links:

https://bit.ly/3azADRA

Dr. John Cush RheumNow ( View Tweet)

Dec 22, 2020

#BestACR20Tweets RT @jeffsparks :Important results from @kmdsilvaMD (newly funded by @RheumResearch): rheumatic patients with COVID with higher risk of hospitalization, ICU admission, CHF, AKI, and VTE than matched comparators. @zach_wallace_md https://t.co/bmuPBf89xD https://t.co/njHYkbenjy

Links:

https://bit.ly/34ywAkJ

Dr. John Cush RheumNow ( View Tweet)

Dec 22, 2020

Exclusive interview with Dr. David Karp, 84th ACR president #ACR20 Dr. Kathryn Dao ( @KDAO2011) interviews the man who inspired her to become a rheumatologist. https://t.co/v7B0OYVOAo https://t.co/UNM2xU1mbM

Links:

https://bit.ly/38o1JZ3

Dr. John Cush RheumNow ( View Tweet)

Dec 21, 2020

Lifestyle and Risk of RA, Lupus: Dr. Janet Pope ( @Janetbirdope) #ACR20 https://t.co/f8a6vHB31e https://t.co/wUcEp1yaNS

Links:

https://bit.ly/38fMfGs

Dr. John Cush RheumNow ( View Tweet)

Dec 21, 2020

The Virtual Classroom Panel: Impact on Medical Education Panelists Dr. Sheila Reyes ( @RHEUMarampa), Dr. Karina Torralba, Dr. Anisha Dua, and Dr. Jeffrey Sparks ( @jeffsparks) discuss medical education in a virtual environment at the #ACR20. https://t.co/IrAaXx4bCU https://t.co/qhRWahe3vH

Links:

https://bit.ly/3nEEOPB

Dr. John Cush RheumNow ( View Tweet)

Dec 21, 2020

FDA issues emergency use authorization (EUA) for the 2nd COVID-19 vaccine from MODERNA. “With the availability of 2 vaccines now for the prevention of COVID-19, the FDA has taken another crucial step in the fight against this global pandemic..." https://t.co/AnmwOZtALk

Links:

https://bit.ly/3ay3ZQs

Dr. John Cush RheumNow ( View Tweet)

Dec 21, 2020

×